Pharmacogenomics of adverse drug reactions: practical applications and perspectives

First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North America

(2009) Benjamin Young et al.   AIDS

Pharmacoeconomic Evaluations of Pharmacogenetic and Genomic Screening Programmes

(2009) Stefan Vegter et al.   PHARMACOECONOMICS

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV

(2008) Bruce R Schackman et al.   AIDS

Efficient Approximation of P-value of the Maximum of Correlated Tests, with Applications to Genome-Wide Association Studies

(2008) Qizhai Li et al.   ANNALS OF HUMAN GENETICS

Influence ofCYP3A5Genetic Polymorphism on Tacrolimus Daily Dose Requirements and Acute Rejection in Renal Graft Recipients

(2008) Lina Quteineh et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin

(2008) Pertti J Neuvonen et al.   CLINICAL PHARMACOKINETICS

Harnessing Economic Drivers for Successful Clinical Implementation of Pharmacogenetic Testing

(2008) PA Deverka et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready?

(2008) AE Shields et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

(2008) L. G. Possuelo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Medical Education: A Key Partner in Realizing Personalized Medicine in Gastroenterology

(2008) Kalpesh K. Patel et al.   GASTROENTEROLOGY

GlutathioneS-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury

(2008) M. Isabel Lucena et al.   HEPATOLOGY

Pharmacogenomic Biomarkers for Prediction of Severe Adverse Drug Reactions

(2008) Magnus Ingelman-Sundberg   NEW ENGLAND JOURNAL OF MEDICINE

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

HLA-B*5701 Screening for Hypersensitivity to Abacavir

(2008) Simon Mallal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

(2008) Tabassome Simon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacogenetic information derived from analysis ofHLAalleles

(2008) Hiroyuki Gatanaga et al.   PHARMACOGENOMICS

Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

(2008) P Brent Ferrell et al.   PHARMACOGENOMICS

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions

(2008) M R Nelson et al.   PHARMACOGENOMICS JOURNAL

Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use

(2008) Felix W Frueh et al.   PHARMACOTHERAPY

The impact of next-generation sequencing technology on genetics

(2008) Elaine R. Mardis   TRENDS IN GENETICS